Sohag University hospital
Sohag, Egypt
Location status: Recruiting
NCT Number: NCT06536946
Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it
Interested in participating?
Request InfoAll sexes
Observational
Sohag, Egypt
Location status: Recruiting
Skin cancer is one of the most common form of cancer worldwide. Cutaneous squamous cell carcinoma is one of most common skin tumers that caused by many factors as ultra violet ,ionizing radiation and others . It was an advanced spectrum ranging from actinic keratosis to invasive and metastatic squmous cell carcinoma. Correct identification of cutaneous squamous cell carcinoma is a challenge as it has both clinically and histopathologically mimickers.
So the aim of this study is to identify the expression of B-catenin in cutaneous Squamous cell carcinoma and its mimickers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Staining of cutanous squamous cell carcinoma and its mimickers by monoclonal antibodies against human B-catenin by immunohistochemical procedures
Time frame: 6 month
Detection of expression of B-catenin in cutaneous squamous cell carcinoma and its mimickers by immunohistochemical procedures using antihuman B-catenin monoclonal antibodies
Contact information is provided by the study sponsor or research team.
Sohag University
Other
Expression of B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06288191
Cutaneous Squamous Cell Carcinoma
Wollstonecraft, New South Wales, Australia
View Trial DetailsNCT04975152
Adenocarcinoma, Carcinoma
Tampa, Florida, United States
View Trial DetailsNCT05076760
Adenocarcinoma, Advanced Cancer
Tampa, Florida, United States
View Trial DetailsNCT06567314
Cutaneous Squamous Cell Carcinoma
Houston, Texas, United States
View Trial Details